Advertisement

Related Videos

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Advertisement

Advertisement




Jan
21
Today In Oncology
IMPT vs IMRT in Oropharyngeal Cancer
Investigational Vaccine Intercepts Cancer Cells in Lynch Syndrome Carriers
Regulatory Agencies Establish Principles of Good AI Use in Drug Development
Genetic Predisposition to Higher Body Mass Index Linked to Mortality After Breast Cancer
Axillary Recurrence With or Without ALND in Patients With Residual Micrometastases After Neoadjuvant Chemotherapy for Breast Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo